Evidence map›Paper›PMID 40155449›Full record

ArticleDiscover oncology2025

The value of predicting breast cancer with a DBT 2.5D deep learning model.

Huandong Niu, Li Li, Ximing Wang, Han Xu

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Abdominal radiology (New York) · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huandong Niu *Department of Radiology, Yantai Zhifu Hospital, No. 51,Qingnian Road, Yantai, People's Republic of China.
Li Li *Department of Clinical Laboratory, Yantai Zhifu Hospital, No. 51,Qingnian Road, Yantai, Shandong, People's Republic of China.
Ximing WangDepartment of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324# Jingwu Road, Jinan, 251000, Shandong, People's Republic of China. wangximing_slyy@126.com.
Han XuDepartment of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324# Jingwu Road, Jinan, 251000, Shandong, People's Republic of China. xuhantsh@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the accuracy and efficacy of a 2.5-dimensional deep learning (DL) model based on digital breast tomosynthesis (DBT) in predicting breast cancer.

methodsThrough a retrospective analysis of data from 361 patients with breast tumor lesions treated at Shandong Provincial Hospital Affiliated to Shandong First Medical University between 2018 and 2020, this study utilized deep convolutional neural networks (DCNN) to automatically extract key features from DBT images. By applying dimensionality reduction and feature fusion selection, a variety of machine learning predictive models based on a 2.5-dimensional feature set were constructed. Additionally, a comprehensive predictive model was developed by combining univariate and multivariate logistic regression analyses with clinical data. The model's performance was assessed using receiver operating characteristic (ROC) curves, area under the curve (AUC) values, and accuracy rates.

resultsIn the test set, DBT 2.5D deep learning-based logistic regression, LightGBM, multilayer perceptron, and comprehensive models achieved accuracies of 72.2%, 75.0%, 79.2%, and 80.6%; AUCs of 0.826, 0.756, 0.859, and 0.871; sensitivities of 63.8%, 70.2%, 80.9%, and 87.2%; specificities of 88.0%, 84.0%, 76.0%, and 68.0%; PPVs of 90.9%, 89.2%, 86.4%, and 83.7%; NPVs of 56.4%, 60.0%, 67.9%, and 73.9%; and F1 scores of 75.0%, 78.6%, 83.5%, and 85.4%, respectively. These results underscore the high efficiency and potential of DBT 2.5D deep learning models in breast cancer diagnosis, particularly the comprehensive model's superior performance across key metrics.

conclusionThe 2.5D deep learning model based on DBT shows good performance in preoperative breast cancer prediction, with its integration with clinical data further enhancing its effectiveness. The combination of deep learning and radiomics offers a viable approach for early breast cancer diagnosis, supporting the development of more accurate personalized diagnostic and treatment strategies.

Indexed as

2.5D deep learningBreast cancerDiagnosisDigital breast tomosynthesisPredictive model

Identifiers

PMID40155449
PMCPMC11953484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.